Together, BluTest Laboratories LTD (“BluTest”) and the Tentamus Group (“Tentamus”) are excited to announce the acquisition of BluTest by Tentamus. Tentamus is thrilled to welcome BluTest as its newest member to the global network of laboratories, on the 28th of May 2021.

“BluTest is not only our first step into Scotland but immensely expands our expertise in the anti-microbials, biocidal, disinfectant, infection control and biofilm market, serving all of our key industries as a key R&D, NPD and TIC provider. Located in Glasgow, the state-of-the art facility enables us to expand our global reach, especially in virology”, emphasizes Abgar Barseyten, CEO Tentamus Group. “It is an exceptional opportunity to grow the network and widen our joint presence well beyond what could be achieved independently”.

Chris Woodall, CEO and founder of BluTest adds: “it was our goal to win an international strategic partner who compliments our service offering. With Tentamus we found exactly that, which enables us to grow even faster now and support our customers’ needs and wants nationally and globally. Joining the worldwide laboratory network of Tentamus opens new opportunities for us and our customers alike. We are delighted and excited about the journey ahead.”

About BluTest Laboratories LTD

BluTest is a microbiology TIC/CRO provider focused on biocide (disinfectant) efficacy testing, new product development (pharmaceutical medical device biocide), disinfectant validation studies, virology and biofilm services. Located in Glasgow, BluTest supports national, European and global clients with close to 20 highly qualified professionals for an over a decade with expertise required now more than ever. Please find further information at http://www.blutest.com

Über die Tentamus Group GmbH

Tentamus Group GmbH was founded in 2011. Tentamus is a global product and safety group with a core presence in Europe, UK, Israel, China, Japan, India and the USA. Accredited and licensed Tentamus Group tests, audits and consults on all products involving the human body (food & feed, pharmaceuticals & medical, agrosciences, cosmetics, agriculture & environment and nutraceutical & supplements). Tentamus Group is represented in over 80 locations worldwide. More than 3,000 highly-trained staff members work in over 3 million square feet of laboratory and office spaces. For further information please visit www.tentamus.com.

Firmenkontakt und Herausgeber der Meldung:

Tentamus Group GmbH
An der Industriebahn 26
13088 Berlin
Telefon: +49 (30) 206038-230
Telefax: +49 (30) 206038-190
http://www.tentamus.com

Ansprechpartner:
Larissa Taylor
Technical Director FDAS
Telefon: +44 (0) 115 912 4265
E-Mail: larissa.taylor@fdas.org
Chris Woodall
CEO BluTest
E-Mail: chris.woodall@blutest.com
Für die oben stehende Story ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.

counterpixel